Ra. Kirken et al., Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells, J LEUK BIOL, 65(6), 1999, pp. 891-899
Janus kinase 3 (JAK3) is a cytoplasmic tyrosine kinase required for T cell
development and activated by cytokines that utilize the interleukin-2 (IL-2
) receptor common gamma chain (gamma(c)). Genetic inactivation of JAK3 is m
anifested as severe combined immunodeficiency disease (SCID) in humans and
mice. These findings have suggested that JAK3 represents a pharmacological
target to control certain lymphoid-derived diseases. Here we provide novel
evidence that AG-490 potently inhibits the autokinase activity of JAK3 and
tyrosine phosphorylation and DNA binding of signal transducer and activator
of transcription 5a and 5b (STAT5a/b), Similar inhibitory effects were obs
erved with other cytokines that use gamma(c). AG-490 also inhibited IL-2-me
diated proliferative growth in human T cells with an IC50 = 25 mu M that wa
s partially recoverable. Moreover, we demonstrate that this inhibitor preve
nted tetanus toroid antigen-specific T cell proliferation and expansion but
failed to block activation of Zap70 or p56Lck after anti-CD3 stimulation o
f human T cells. Taken together, these findings suggest that AG-490 inhibit
s the JAK3-mediated Type II signaling pathway but not the T cell receptor-d
erived Type I pathway and possesses therapeutic potential for T cell-derive
d pathologies such as graft-versus-host disease, allergy, and autoimmune di
sorders.